National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Neurasthenia is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Primary Neurasthenia
- Cardiac Neurosis
- Chronic Asthenia
- Da Costa's Syndrome
- Effort Syndrome
- Functional Cardiovascular Disease
- Soldier's Heart
- Subacute Asthenia
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Myalgic Encephalomyelitis
- Myasthenia Gravis
- Panic-Anxiety Syndrome
The word "neurasthenia" is a term that has fallen into disuse among psychiatrists in the United States and Australia. It remains in use in the United Kingdom. Where it is used, it covers a wide spectrum of symptoms including the sensation of pain or of numbness in various parts of the body, chronic fatigue, weakness, anxiety, and fainting. Additional findings associated with this term may include rapid intense heartbeat that may be irregular (palpitations, tachycardia); cold, clammy hands and feet; abnormally rapid breathing (hyperventilating); dizziness or faintness; periodic sighing; and/or sweating for no apparent reason.
Major symptoms of neurasthenia include a feeling of weakness or fatigue, which may be accompanied by chest pain. A rapid intense heartbeat, which may be irregular (palpitations, tachycardia) can occur. The individual may have cold, clammy hands and feet. Hyperventilation causes a dizzy or faint feeling. Sighing periodically, or sweating for no reason are other symptoms associated with neurasthenia. This condition may occur along with, or after, depression or other psychological disorders.
Angiopathic neurasthenia (also called angioparalytic neurasthenia, or pulsating neurasthenia) refers to a mild form of Neurasthenia in which the patient feels a pulsing or throbbing sensation throughout the entire body. Gastric neurasthenia is a mild form of neurasthenia accompanied by digestive dysfunction and stomach enlargement (distention), and by indigestion (dyspepsia). Neurasthenia gravis refers to an extreme and persistent form of neurasthenia. Neurasthenia precox (or primary neurasthenia) tends to occur most often in adolescents and is characterized by nervous exhaustion.
Neurasthenia is a mental disorder caused by emotional stress or anxiety. It is not caused by any underlying physical (organic) problems even though physical discomfort can be present.
Neurasthenia is a fairly common disorder which may occur in childhood, adolescence or adulthood. It affects males and females in equal numbers.
Symptoms of the following disorders can be similar to those of neurasthenia. Comparisons may be useful for a differential diagnosis:
In hyperthyroidism, the thyroid gland is overactive and produces an excessive amount of thyroid hormones. Symptoms may include sweating, nervousness, emotional instability, fatigue, insomnia, increased appetite, weight loss, or diarrhea. A rapid heartbeat (tachycardia) or rapid twitching of the muscle of the heart's upper chambers (atrial fibrillation) may occur. Other symptoms may include sensitivity to heat (heat intolerance), trembling of the hands, or muscle weakness. A slight swelling in the neck just below the Adam's apple (due to thyroid gland enlargement), warm smooth skin, or bulging of the eyes (exophthalmos) may be present. In older people depression or heart failure may occur. A blood test for hyperthyroidism can rule it out as a cause for neurasthenia. (For more information on disorders of the thyroid, choose "thyroid" as your search term in the Rare Disease Database.)
Myalgic encephalomyelitis is thought to be an infectious disorder affecting the central, peripheral and autonomic nervous systems and the muscles. Major symptoms may include general exhaustion, headache, muscle pain, weakness, and possible mental changes. The exact cause of this disorder is unknown, but researchers believe a virus associated with an immune system abnormality may be responsible. Adults are most commonly affected, with more cases seen in females than in males. (For more information on this disorder, choose "Myalgic Encephalomyelitis" as your search term in the Rare Disease Database.)
Myasthenia gravis (MG) is a chronic neuromuscular disease characterized by weakness and abnormally rapid fatigue of the voluntary muscles, with improvement following rest. Any group of muscles may be affected, but those around the eyes and the muscles used for swallowing are the most commonly involved. In the majority of cases, the course of the disease is punctuated with periods of greater and lesser weakness. Short-term aggravation of symptoms can be provoked by a host of factors, including excessive physical activity, emotional upset, menstruation, and pregnancy. Complete spontaneous disappearance of symptoms has been reported in rare instances. (For more information on this disorder, choose "Myasthenia Gravis" as your search term in the Rare Disease Database.)
The main feature of panic-anxiety syndrome is the recurrence of panic attacks. Psychological symptoms may include intense apprehension, unreasonable fear of dying or impending doom, fear of becoming insane, or dread of losing control of the self. Physical manifestations are generally those commonly associated with panic or anxiety such as difficulty in breathing, irregular heartbeat, sweating, trembling and faintness. In addition, patients may experience chest pain, feelings of unreality, abnormal sensations (burning or pricking), dizziness, or hot and cold flashes. The symptoms usually become apparent in late adolescence or early adulthood. Attacks, which can occur at any time, usually last only minutes, though in rare cases they may last hours. (For more information on this disorder, choose "Panic-Anxiety" as your search term in the Rare Disease Database.)
Testing can be done to rule out any underlying physical (organic) causes that might lead to the symptoms of neurasthenia. Treatment includes reassuring the patient that the symptoms are not due to any physical (organic) causes. Counseling will be of benefit to the patient in learning how to control feelings of stress and anxiety. If necessary, biofeedback, sedatives or tranquilizers may be prescribed.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government website.
For information about clinical trials being conducted at the National Institutes of Health (NIH) in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Cecil Textbook of Medicine, 18th Ed.: James B. Wyngaarden, and Lloyd H. Smith, Jr., Editors; W.B. Saunders Co., 1988. Pp. 1322, 1324, 2124-2125, 2286.
Internal Medicine, 2nd Ed.: Jay H. Stein, ed.-in-chief; Little, Brown and Co., 1987. Pp. 374-375.
The Merck Manual, Volume 1, 15th Ed.: Robert Berkow, M.D., ed.-in-chief; Merck, Sharp, and Dohme Laboratories, 1987. Pp. 345.
Feelings of Fatigue and Psychopathology: A Conceptual History. G.E. Berrios; Compr Psychiatry (Mar-Apr 1990; issue 31 (2)). Pp. 140-151.
Old Wine in New Bottles: Neurasthenia and 'Me'. S. Wessely; Psychol Med (Feb 1990; issue 20 (1)). Pp. 35-53.
Neurasthenia in the 1980's: Chronic Mononucleosis, Chronic Fatigue Syndrome and Anxiety and Depressive Disorders. D. B. Greenberg; Psychosomatics (Spring 1990; issue 31 (2)). Pp. 129-137.
National Mental Health Consumers' Self-Help Clearinghouse
1211 Chestnut Street
Philadelphia, PA 19107-6312
Mental Health America
2000 N. Beauregard Street, 6th Floor
Alexandria, VA 22314-2971
National Alliance on Mental Illness
3803 N. Fairfax Drive
Arlington, VA 22203-
NIH/National Institute of Mental Health
Health Science Writing, Press and Dissemination Branch
6001 Executive Boulevard
Room 8184, MSC 9663
Bethesda, MD 20892-9663
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 4/25/2008
Copyright 1991, 1998, 2005 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.